IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,886 | +135.8% | 41,571 | +113.3% | 0.02% | +266.7% |
| Q2 2023 | $800 | -99.9% | 19,493 | +53.5% | 0.01% | -14.3% |
| Q3 2022 | $562,000 | -79.1% | 12,698 | -82.5% | 0.01% | -75.9% |
| Q2 2022 | $2,686,000 | +526.1% | 72,557 | +526.0% | 0.03% | +866.7% |
| Q1 2022 | $429,000 | +8.9% | 11,591 | -10.4% | 0.00% | +50.0% |
| Q4 2021 | $394,000 | -40.4% | 12,932 | -34.4% | 0.00% | -33.3% |
| Q3 2021 | $661,000 | +47.2% | 19,721 | +75.3% | 0.00% | +50.0% |
| Q2 2021 | $449,000 | -78.2% | 11,249 | -75.4% | 0.00% | -81.8% |
| Q1 2021 | $2,060,000 | +16.0% | 45,808 | +45.8% | 0.01% | +22.2% |
| Q4 2020 | $1,776,000 | -30.9% | 31,414 | -42.0% | 0.01% | -43.8% |
| Q3 2020 | $2,569,000 | +585.1% | 54,135 | +750.4% | 0.02% | +433.3% |
| Q2 2020 | $375,000 | -36.5% | 6,366 | -49.1% | 0.00% | -50.0% |
| Q1 2020 | $591,000 | +19.9% | 12,503 | +53.1% | 0.01% | +50.0% |
| Q4 2019 | $493,000 | -19.3% | 8,165 | -20.0% | 0.00% | -20.0% |
| Q3 2019 | $611,000 | -10.8% | 10,206 | -4.3% | 0.01% | 0.0% |
| Q2 2019 | $685,000 | +220.1% | 10,660 | +305.0% | 0.01% | +150.0% |
| Q1 2019 | $214,000 | -69.4% | 2,632 | -79.6% | 0.00% | -66.7% |
| Q4 2018 | $699,000 | +286.2% | 12,925 | +269.1% | 0.01% | +500.0% |
| Q3 2018 | $181,000 | -94.5% | 3,502 | -95.6% | 0.00% | -96.7% |
| Q2 2018 | $3,281,000 | +758.9% | 78,744 | +809.1% | 0.03% | +900.0% |
| Q1 2018 | $382,000 | +221.0% | 8,662 | +269.2% | 0.00% | +200.0% |
| Q3 2017 | $119,000 | -62.9% | 2,346 | -62.9% | 0.00% | -66.7% |
| Q2 2017 | $321,000 | +65.5% | 6,315 | +30.9% | 0.00% | +50.0% |
| Q1 2017 | $194,000 | -77.5% | 4,826 | -73.2% | 0.00% | -71.4% |
| Q4 2016 | $861,000 | +23.5% | 18,004 | +4.6% | 0.01% | +40.0% |
| Q1 2016 | $697,000 | -21.9% | 17,214 | +19.3% | 0.01% | -16.7% |
| Q4 2015 | $893,000 | – | 14,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |